RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)

NCT03813641 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Raltitrexed
DRUG: Capecitabine

Sponsor

Shenzhen People's Hospital